CXCL10 and lobular neoplasia: In the retrospective study conducted by Wang and Cui, serum levels of CXCL10 presented satisfactory ROC parameters for diagnosis of LN in SLE patients with an AUC of 0.75, Sn of 76.47% and Sp of 68.48%, but combining serum CXCL9, CXCL10 and CXCL11 demonstrated an improved receiver operating characteristic (ROC) profile with an AUC of 0.94, Sn 86.76 and Sp of 83.7% [139].